Serum Proteomes Distinguish Children Developing Type 1 Diabetes in a Cohort With HLA-Conferred Susceptibility

We determined longitudinal serum proteomics profiles from children with HLA-conferred diabetes susceptibility to identify changes that could be detected before seroconversion and positivity for disease-associated autoantibodies. Comparisons were made between children who seroconverted and progressed to type 1 diabetes (progressors) and those who remained autoantibody negative, matched by age, sex, sample periodicity, and risk group. The samples represented the prediabetic period and ranged from the age of 3 months to 12 years. After immunoaffinity depletion of the most abundant serum proteins, isobaric tags for relative and absolute quantification were used for sample labeling. Quantitative proteomic profiles were then measured for 13 case-control pairs by high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS). Additionally, a label-free LC-MS/MS approach was used to analyze depleted sera from six case-control pairs. Importantly, differences in abundance of a set of proteins were consistently detected before the appearance of autoantibodies in the progressors. Based on top-scoring pairs analysis, classification of such progressors was observed with a high success rate. Overall, the data provide a reference of temporal changes in the serum proteome in healthy children and children progressing to type 1 diabetes, including new protein candidates, the levels of which change before clinical diagnosis.

[1]  Rainer Breitling,et al.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.

[2]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[3]  R. Lahesmaa,et al.  Pre-processing of Orbitrap higher energy collisional dissociation tandem mass spectra to reduce erroneous iTRAQ ratios. , 2012, Rapid communications in mass spectrometry : RCM.

[4]  Min Chen,et al.  The complement system in systemic autoimmune disease. , 2010, Journal of autoimmunity.

[5]  Olli Simell,et al.  Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes , 2008, The Journal of experimental medicine.

[6]  X. Lao,et al.  Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis , 2012, Hepatology International.

[7]  Derek J. Bailey,et al.  The One Hour Yeast Proteome* , 2013, Molecular & Cellular Proteomics.

[8]  Eugene Kolker,et al.  The necessity of adjusting tests of protein category enrichment in discovery proteomics , 2010, Bioinform..

[9]  G. Romeo,et al.  The multifaceted role of profilin-1 in adipose tissue inflammation and glucose homeostasis , 2014, Adipocyte.

[10]  Trong Khoa Pham,et al.  Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). , 2007, Journal of proteome research.

[11]  Xiaomin Song,et al.  iTRAQ experimental design for plasma biomarker discovery. , 2008, Journal of proteome research.

[12]  S. Baron,et al.  Lipoproteins account for part of the broad non-specific antiviral activity of human serum. , 1999, Antiviral research.

[13]  A. Hämäläinen,et al.  Feasibility of genetic and immunological prediction of Type I diabetes in a population-based birth cohort , 2001, Diabetologia.

[14]  Qibin Zhang,et al.  Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes , 2013, The Journal of experimental medicine.

[15]  Paul Bowness,et al.  Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing Spondylitis* , 2011, Molecular & Cellular Proteomics.

[16]  Jianhe Peng,et al.  A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses , 2011, Proteomics.

[17]  Daniel Q. Naiman,et al.  Classifying Gene Expression Profiles from Pairwise mRNA Comparisons , 2004, Statistical applications in genetics and molecular biology.

[18]  Gilbert S Omenn,et al.  Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: Systematic variation between sample types and calibration of mass spectrometry data , 2005, Proteomics.

[19]  J. She,et al.  Proteomic Technologies for the Discovery of Type 1 Diabetes Biomarkers , 2010, Journal of diabetes science and technology.

[20]  Christoph H Borchers,et al.  Dietary patterns and ethnicity are associated with distinct plasma proteomic groups. , 2012, The American journal of clinical nutrition.

[21]  Hye-Seung Lee,et al.  The Environmental Determinants of Diabetes in the Young (TEDDY) Study: predictors of early study withdrawal among participants with no family history of type 1 diabetes , 2011, Pediatric diabetes.

[22]  Sean L Seymour,et al.  The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S , 2007, Molecular & Cellular Proteomics.

[23]  Tero Aittokallio,et al.  Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling. , 2010, Journal of autoimmunity.

[24]  Sean L. Seymour,et al.  CysTRAQ - A combination of iTRAQ and enrichment of cysteinyl peptides for uncovering and quantifying hidden proteomes. , 2012, Journal of proteomics.

[25]  E. Bonifacio,et al.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. , 2013, JAMA.

[26]  D. Goodlett,et al.  Multiplexed and data-independent tandem mass spectrometry for global proteome profiling. , 2014, Mass spectrometry reviews.

[27]  S. Alvarez,et al.  Comprehensive comparison of iTRAQ and label-free LC-based quantitative proteomics approaches using two Chlamydomonas reinhardtii strains of interest for biofuels engineering. , 2012, Journal of proteome research.

[28]  Olli Simell,et al.  Innate Immune Activity Is Detected Prior to Seroconversion in Children With HLA-Conferred Type 1 Diabetes Susceptibility , 2014, Diabetes.

[29]  P. Lichter,et al.  The human vitronectin (complement S-protein) gene maps to the centromeric region of 17q , 1992, Human Genetics.

[30]  Sean L Seymour,et al.  Nonlinear fitting method for determining local false discovery rates from decoy database searches. , 2008, Journal of proteome research.

[31]  Daniel Q. Naiman,et al.  Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data , 2005, Bioinform..

[32]  J. Ilonen,et al.  Enterovirus infections are associated with the induction of β‐cell autoimmunity in a prospective birth cohort study , 2003, Journal of medical virology.

[33]  Matthew E Monroe,et al.  A proteomic study of the HUPO Plasma Proteome Project's pilot samples using an accurate mass and time tag strategy , 2005, Proteomics.

[34]  Tero Aittokallio,et al.  PolyAlign: A Versatile LC-MS Data Alignment Tool for Landmark-Selected and -Automated Use , 2011, International journal of proteomics.

[35]  R. Lahesmaa,et al.  Quantitative Proteomics Analysis of the Nuclear Fraction of Human CD4+ Cells in the Early Phases of IL-4-induced Th2 Differentiation , 2010, Molecular & Cellular Proteomics.

[36]  M. Turner,et al.  The role of mannose-binding lectin in health and disease. , 2003, Molecular immunology.

[37]  M. Knip,et al.  Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. , 1998, The Journal of clinical investigation.

[38]  R. Zuerner,et al.  Global Proteome Analysis of Leptospira interrogans , 2009, Journal of proteome research.

[39]  R. Aebersold,et al.  A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas* , 2011, Molecular & Cellular Proteomics.

[40]  Rachel M. Adams,et al.  Systematic comparison of label-free, metabolic labeling, and isobaric chemical labeling for quantitative proteomics on LTQ Orbitrap Velos. , 2012, Journal of proteome research.

[41]  Jingxuan Liu,et al.  Elevation of transcription factor Islet-1 levels in vivo increases β-cell function but not β-cell mass , 2012, Islets.

[42]  W. Liang,et al.  9) TM4 Microarray Software Suite , 2006 .

[43]  R. Cole,et al.  The Plasma Proteome Identifies Expected and Novel Proteins Correlated with Micronutrient Status in Undernourished Nepalese Children 1 – 3 , 2013 .

[44]  J. Sodetz,et al.  Complement: Terminal Pathway , 2001 .

[45]  J. van der Greef,et al.  The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.

[46]  M. Rewers,et al.  Adiponectin dysregulation and insulin resistance in type 1 diabetes. , 2012, The Journal of clinical endocrinology and metabolism.

[47]  F. Pociot,et al.  Screening newborns for candidate biomarkers of type 1 diabetes , 2010, Archives of physiology and biochemistry.

[48]  J. Ilonen,et al.  Coxsackievirus B1 Is Associated With Induction of β-Cell Autoimmunity That Portends Type 1 Diabetes , 2014, Diabetes.

[49]  J. She,et al.  Discovery and Validation of Serum Protein Changes in Type 1 Diabetes Patients Using High Throughput Two Dimensional Liquid Chromatography-Mass Spectrometry and Immunoassays* , 2011, Molecular & Cellular Proteomics.

[50]  Ronald J Moore,et al.  Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset. , 2008, Journal of proteome research.

[51]  Steven A Carr,et al.  Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics. , 2011, Circulation research.

[52]  Peter Rossing,et al.  Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients , 2010, Clinical Proteomics.

[53]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[54]  J. Ilonen,et al.  Cord Serum Lipidome in Prediction of Islet Autoimmunity and Type 1 Diabetes , 2013, Diabetes.